Osmotic controlled-release oral delivery system
OROS (Osmotic [Controlled] Release Oral [Delivery] System) is an advanced controlled release oral drug delivery system in the form of a rigid tablet with a semi-permeable outer membrane and one or more small laser drilled holes in it. As the tablet passes through the body, water is absorbed through the semi-permeable membrane via osmosis, and the resulting osmotic pressure is used to push the active drug through the opening in the tablet. OROS is a trademarked name owned by ALZA Corporation, which pioneered the use of osmotic pumps for oral drug delivery.[1]
List of OROS medications
OROS medications include:[1][2]
- Adalat OROS (nifedipine)
- Alpress LP (prazosin)
- Cardura XL (doxazosin)
- Concerta (methylphenidate)
- Covera HS (verapamil)
- Ditropan XL/Lyrinel XL (oxybutynin)
- DynaCirc CR (isradipine)
- Glucotrol XL (glipizide)
- Invega (paliperidone)
- Jurnista/Exalgo (hydromorphone)
- Procardia XL (nifedipine)
- Volmax (salbutamol)
References
- 1 2 Malaterre, V; Ogorka, J; Loggia, N; Gurny, R (November 2009). "Oral osmotically driven systems: 30 years of development and clinical use.". European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 73 (3): 311–23. doi:10.1016/j.ejpb.2009.07.002. PMID 19602438.
- ↑ Bass, DM; Prevo, M; Waxman, DS (2002). "Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.". Drug safety 25 (14): 1021–33. PMID 12408733.
|
This article is issued from Wikipedia - version of the Saturday, February 13, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.